Originally, CSPG4 was identified in human melanoma cells (11) and neuroectoderm-derived tumors (13, 14) and has been suggested to be expressed in central nervous system cells during development/differentiation playing a critical role in proliferation and angiogenesis. This evidence concerns the gene CSPG4 and melanoma.